Rezension:

Can you put it on the scales, please? erexin v forum Patients with advanced breast cancer living in England and Wales will not be allowed routine access to Novartis' Afinitor on the National Health Service, following a decision from the National Institute for Health and Care Excellence that has angered the company and charities.

Bewertung: